Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan, moxonidine, and low-sodium diet crossover trial in former pre-eclamptic women
2014-002524-27Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of losartan and moxonidine in hypertension (HTN) (4 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Mean 24-hour blood pressure, Daytime systolic blood pressure and 3 more. Started Dec 2014; status: terminated.
02
Drugs
losartanmoxonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2014-002524-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002524-27.